The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for CTL Trusteeship Ltd

CTL/SAST/26-27/00244 September 30, 2026 1) National Stock Exchange of India Limited Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai – 400051. 2) BSE Limited Floor 25, P. J. Towers, Dalal Street, Mumbai, Mumbai – 400001. 3) Ajanta Pharma Limited 4) Ajanta Tower, 54-A, M.V. Road, Chakala, Andheri (East), Mumbai 400093 Dear Sir/Madam, Sub: Disclosure pursuant to Regulation 29 (2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 in relation to pledge of equity shares of Ajanta Pharma Limited Pursuant to the disclosure required to be made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, please find attached the disclosure in respect of the additional pledged equity shares of Ajanta Pharma Limited (“Target Company”) to secure the issuance of secured, unlisted, redeemable and non-convertible debentures having face value of INR 10,00,000 (Indian Rupees Ten Lakh) each aggregating up to INR 33,73,00,00,000 (Indian Rupees Three Thousand Three Hundred and Seventy Three Crores) issued/ to be issued by Lenexis Foodworks Private Limited (“LFPL Debentures”) and secured, unlisted, redeemable and non-convertible debentures having face value of INR 10,00,000 (Indian Rupees Ten Lakh) each aggregating up to INR 500,00,00,000 (Indian Rupees Five Hundred Crore only) to be issued by Inspira Realty 2 Private Limited (“IR2PL Debentures”) (the LFPL Debentures and the IR2PL Debentures shall collectively be referred to as the “Debentures”) in favour of CTL Trusteeship Limited in the capacity of common security trustee (“Common Security Trustee”) for the benefit of the debenture trustee(s) of the Debentures and the respective Debenture holders. Please take the same on record and disseminate the same. For CTL Trusteeship Limited Authorised Signatory Name: Deesha Srikkanth Designation: Senior Vice President Place: Mumbai Date: September 30, 2026 Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Ajanta Pharma Limited Name of the Target Company (TC) CTL Trusteeship Limited acting as Common Name(s) of the acquirer and Persons Acting in Concert (PAC) Security Trustee for the benefit of the debenture with the acquirer trustee(s) of the Debentures and the respective Debenture holders Whether the acquirer belongs to Promoter/Promoter group BSE Limited Name(s) of the Stock Exchange(s) where the shares of TC are National Stock Exchange of India Limited Listed Number % w.r.t.total % w.r.t. total share/voting diluted Details of the acquisition / disposal as follows capital wherever share/voting applicable(*) capital of the TC (**) Pledged Pledged shares: Pledged shares: Before the acquisition/disposal under consideration, holding shares: 5.31% 5.30% 66,32,651 Encumbered Encumbered a) Shares carrying voting rights Encumbere shares shares b) Shares in the nature of encumbrance (pledge/ lien/ d shares (including (including non-disposal undertaking/ others) (including pledged pledged c) Voting rights (VR) otherwise than by shares pledged shares): shares): d) Warrants/convertible securities/any other instrument shares): 13.54% 13.52% that entitles the acquirer to receive shares carrying 1,69,12,924 voting rights in the T C (specify holding in each category) e) Total (a+b+c+d) Check Note (1) below Details of acquisition/sale: a) Shares carrying voting rights acquired/sold b) VRs acquired /sold otherwise than by shares c) Warrants/convertible securities/any other instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each Pledged category) acquired/sold shares: Pledged shares: Pledged shares: d) Shares encumbered / invoked/released by the acquirer 26,21,067 2.10% 2.10% e) Total (a+b+c+/-d) Pledged Pledged Pledged shares: After the acquisition/sale, holding of: shares: shares: 7.40% 92,53,718 7.41% a) Shares carrying voting rights [Check Note b) Shares encumbered with the acquirer (2) below] Encumber Encumbered c) VRs otherwise than by shares ed shares shares d) Warrants/convertible securities/any other instrument Encumbered (including (including that entitles the acquirer to receive shares carrying shares pledged pledged shares): voting rights in the TC (specify holding in each (including shares): 13.53% category) after acquisition pledged 13.53% e) Total (a+b+c+d) shares): 1,6332,924 Check Note (1) below [Check Note (3) below] By way of share pledge created over the equity Mode of acquisition / sale (e.g. open market / off-market / shares of the Target Company in favour of CTL public issue / rights issue / preferential allotment / inter-se Trusteeship Limited transfer etc). 2161067 shares pledged on July 24, 2026 & Date of acquisition / Release of shares / VR or date of receipt 460000 shares pledge on September 28, 2026 of intimation of allotment of shares, whichever is applicable Rs. 24,98,71,248 (12,49,35,624 Equity shares Equity share capital / total voting capital of the TC before the having face value of Rs 2 each) said acquisition / sale Rs. 24,98,71,248 (12,49,35,624 Equity shares Equity share capital/ total voting capital of the TC after the having face value of Rs 2 each) said acquisition / sale Rs. 25,01,71,848 (12,50,85,924 Equity shares Total diluted share/voting capital of the TC after the said having face value of Rs 2 each) acquisition Note (1): Under the terms of the transaction documents entered in relation to the Debentures, Aayush Agrawal Trust, Aayush Agrawal and Gabs Investments Private Limited have undertaken certain covenants which are in the nature of ‘encumbrance’ (as defined under the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011) on all the shares held by them in the Target Company. Note (2): The pledge has been created over: (i) 6453718 shares of the Target Company by Aayush Agrawal Trust acting though its trustee Aayush Agrawal; and (ii) 2770000 shares of the Target Company by Gabs Investment Private Limited; and (iii) 30000 shares of the Target Company by Aayush Agrawal Note (3): The total shares encumbered by way of covenant and pledge are: (i) 13532924 shares of the Target Company by Aayush Agrawal Trust acting though its trustee Aayush Agrawal; and (ii) 2770000 shares of the Target Company by Gabs Investment Private Limited; and (iii) 30000 shares of the Target Company by Aayush Agrawal (*) Total share capital/ voting capital to be taken as per the latest filing done by the company to the Stock Exchange under Clause 35 of the listing Agreement. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. Signature of the acquirer: For CTL Trusteeship Limited Authorised Signatory Name: Deesha Srikkanth Designation: Senior Vice President Place: Mumbai Date: September 30, 2026